Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference

New Brunswick, NJ (January 27^th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in Citi’s 2022 Virtual Healthcare Conference on Wednesday, February 23^rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.